Logo-jcvtr

J Cardiovasc Thorac Res. 2022;14(3): 191-196. doi: 10.34172/jcvtr.2022.32
PMID: 36398048        PMCID: PMC9617061

Original Article

The incidence and mortality rates due to stroke and myocardial infarction following implementing the package of essential non-communicable diseases; A historical cohort study

Sayed Ali Ayat 1 ORCID, Shayeste Rostami 1 ORCID, Reza Khadivi 1 * ORCID

Cited by CrossRef: 0

1- Kataria I, Morrell L, Allman G, Loffreda G, Laatikainen T, Miranda J, Mahendradhata Y, Nugent R. Using implementation science for WHO noncommunicable disease technical packages in low-and middle-income countries: a scoping review. Front Health Serv. 2026;6 [Crossref]
2- Marvi A, Sadeghi M, Aarabi M, Shabanikiya H, Kokabisaghi F, Houshmand E, Vafaee‐Najar A. A Scoping Review of Noncommunicable Disease Programs Evaluation: Bridging Gaps and Improving Frameworks in Primary Healthcare. Health Science Reports. 2026;9(1) [Crossref]
3- Rabiee Rad M, Darouei B, Ghasempour Dabaghi G, Amani‐Beni R, Bagheri F, Shahidi S, Mohammadifard N, Sabeti F, Azizian S, Pourmoghaddas A, Shirani S, Sabri M, Sarrafzadegan N. National and Subnational Trends in Ischemic Heart Disease Burden in Iran, 1990–2023: A Systematic Review. Clinical Cardiology. 2026;49(10) [Crossref]
4- Mendis S, Graham I. Prevention and control of cardiovascular disease in “real-world” settings: sustainable implementation of effective policies. Front Cardiovasc Med. 2024;11 [Crossref]
5- Iravani M, Khadivi R. Intrahospital Mortality Rate after the Implementation of the Second Phase of the Health Sector Reform in Comparison with Before that in Iran. 2024;15 [Crossref]